Literature DB >> 27453711

A Software App for Radiotherapy with In-situ Dose-painting using high Z nanoparticles.

M Jermoumi1, A Yucel2, Y Hao2, G Cifter1, E Sajo2, W Ngwa1.   

Abstract

The purpose of this work is to develop an user friendly and free-to-download application software that can be employed for modeling Radiotherapy with In-situ Dose-painting (RAID) using high-Z nanoparticles (HZNPs). The RAID APP is software program written in Matlab (Mathworks, Natick, MA, USA) based on deterministic code developed to simulate the space-time intra-tumor HZNPs biodistribution within the tumor, and the corresponding dose enhancement in response to low dose rate (LDR) brachytherapy of I-125, Pd-102, Cs-131 and kilovoltage x-rays such as 50 keV and 100 keV. Through the GUI of RAID APP, the user will be directed to different features to compute various parameters related to the dose enhancement and the biodistribution of NPs within high risk tumor sub-volumes. The software was developed as tool for research purposes with potential for subsequent development to guide dose-painting treatment planning using radiosensitizers such as gold (Au) and platinum (Pt).

Entities:  

Keywords:  Dose painting; dose enhancement; high atomic number nanoparticles

Year:  2015        PMID: 27453711      PMCID: PMC4955866          DOI: 10.1007/978-3-319-19387-8_151

Source DB:  PubMed          Journal:  IFMBE Proc        ISSN: 1680-0737


  12 in total

Review 1.  Gold nanoparticles as novel agents for cancer therapy.

Authors:  S Jain; D G Hirst; J M O'Sullivan
Journal:  Br J Radiol       Date:  2011-10-18       Impact factor: 3.039

2.  Localized dose enhancement to tumor blood vessel endothelial cells via megavoltage X-rays and targeted gold nanoparticles: new potential for external beam radiotherapy.

Authors:  Ross I Berbeco; Wilfred Ngwa; G Mike Makrigiorgos
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-12-14       Impact factor: 7.038

3.  Gold nanoparticle enhancement of stereotactic radiosurgery for neovascular age-related macular degeneration.

Authors:  Wilfred Ngwa; G Mike Makrigiorgos; Ross I Berbeco
Journal:  Phys Med Biol       Date:  2012-09-21       Impact factor: 3.609

4.  The use of gold nanoparticles to enhance radiotherapy in mice.

Authors:  James F Hainfeld; Daniel N Slatkin; Henry M Smilowitz
Journal:  Phys Med Biol       Date:  2004-09-21       Impact factor: 3.609

5.  New potential for enhancing concomitant chemoradiotherapy with FDA approved concentrations of cisplatin via the photoelectric effect.

Authors:  Yucel Altundal; Gizem Cifter; Alexandre Detappe; Erno Sajo; Panagiotis Tsiamas; Piotr Zygmanski; Ross Berbeco; Robert A Cormack; Mike Makrigiorgos; Wilfred Ngwa
Journal:  Phys Med       Date:  2014-12-06       Impact factor: 2.685

6.  Brachytherapy application with in situ dose painting administered by gold nanoparticle eluters.

Authors:  Neeharika Sinha; Gizem Cifter; Erno Sajo; Rajiv Kumar; Srinivas Sridhar; Paul L Nguyen; Robert A Cormack; G Mike Makrigiorgos; Wilfred Ngwa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-12-05       Impact factor: 7.038

7.  The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/x-ray sources.

Authors:  Sang Hyun Cho; Bernard L Jones; Sunil Krishnan
Journal:  Phys Med Biol       Date:  2009-07-27       Impact factor: 3.609

8.  Nanoparticle location and material dependent dose enhancement in X-ray radiation therapy.

Authors:  Mainul Hossain; Ming Su
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2012-09-27       Impact factor: 4.126

9.  Radiotherapy in the presence of contrast agents: a general figure of merit and its application to gold nanoparticles.

Authors:  Stephen J McMahon; Marcus H Mendenhall; Suneil Jain; Fred Currell
Journal:  Phys Med Biol       Date:  2008-09-24       Impact factor: 3.609

10.  In vitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with I-125 brachytherapy seeds.

Authors:  Wilfred Ngwa; Houari Korideck; Amin I Kassis; Rajiv Kumar; Srinivas Sridhar; G Mike Makrigiorgos; Robert A Cormack
Journal:  Nanomedicine       Date:  2012-10-02       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.